Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Kidney Cancer
Lenvatinib Warrants Further Study in mRCC
Kidney Cancer
Read More ›
Renal Cell Carcinoma Roundup: Immune checkpoint inhibitors show promise
Kidney Cancer
Read More ›
No Role for Adjuvant Sorafenib or Sunitinib in Locally Advanced Kidney Cancer
Kidney Cancer
Read More ›
Highest Response Rate to Date With a Third-Line VEGF Inhibitor, Pazopanib, in Metastatic Renal Cell Carcinoma
Kidney Cancer
Read More ›
Sequential Therapy for Renal Cell Carcinoma
By
Daniel C. Cho, MD
Kidney Cancer
Read More ›
Angiotensin System Inhibitors Extend Survival in Patients With Metastatic Renal Cell Carcinoma
Kidney Cancer
Read More ›
Antiangiogenic Tyrosine Kinase Inhibitors and Their Diverse Spectra of Inhibitory Activity: Implications for Personalized Therapy in Renal Cell Carcinoma
By
Sanjiv S. Agarwala, MD
Kidney Cancer
Read More ›
Sequential Therapy for Renal Cell Carcinoma
By
Daniel C. Cho, MD
Kidney Cancer
Read More ›
Frontline Therapy of Metastatic Renal Cell Carcinoma: Pazopanib as Effective as Sunitinib
By
Phoebe Starr
Kidney Cancer
Read More ›